drugset / Trial / NCT00233389

Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer

NCT00233389

Phase 4 Completed 301 enrolled Otsuka Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To examine the efficacy of continued administration of rebamipide following bacteria eradication therapy in patients with H. pylori-positive active gastric ulcer in a placebo-controlled, double-blind study

Timeline

Start
2004-04-30
Primary completion
2005-09-01
Completion
2005-09-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Rebamipide Small molecule

Indications